News
We conclude that a single dose of azithromycin (30 mg/kg) is safe and effective for the treatment of uncomplicated AOM in children.
Conclusion: A single-dose intravenous salbutamol bolus of 15 µg/kg administered over 10 mins in the initial treatment of children with acute severe asthma in the emergency department has the ...
Opens in a new tab or window At its meeting on Tuesday, the CDC's Advisory Committee on Immunization Practices (ACIP) considered whether the U.S. should move to single-dose human papillomavirus ...
The FDA has accepted for review the sBLA for fremanezumab-vfrm for the prevention of episodic migraine in pediatric patients aged 6 to-17 years weighing at least 45 kg.
The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results